Vertex Pharmaceuticals

Pharmaceutical company specializing in rare diseases, especially cystic fibrosis. Limits executive hiring from oncology-focused pharma (Genentech, Bristol Myers) because oncology practices - fast patient recruitment, broad trials, blockbuster commercialization - are maladaptive for rare disease development. Maintains <8% senior leadership migration from non-rare-disease companies.